XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses    
Research and development $ 13,531 $ 7,410
General and administrative 4,433 3,459
Total operating expenses 17,964 10,869
Loss from operations (17,964) (10,869)
Other income, net 1,409 574
Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds 10,060 (13,336)
Net loss (6,495) (23,631)
Other comprehensive loss:    
Unrealized loss on available-for-sale securities, net (44)  
Comprehensive loss $ (6,539) $ (23,631)
Net loss per share, basic $ (0.08) $ (0.79)
Net loss per share, diluted $ (0.08) $ (0.79)
Weighted-average common shares outstanding, basic 77,126,763 29,989,400
Weighted-average common shares outstanding, diluted 77,126,763 29,989,400